Both in Pharmaceuticals
MacroGenics vs Yarrow Bioscience
Over the past year MGNX returned −42.6% and YARW returned −42.5%; their daily moves had a correlation of 0.04.
MGNX −42.6% YARW −42.5%Growth of $1, one year, split-adjusted
| Metric | MGNX | YARW |
|---|---|---|
| Price | $2.30 | $15.53 |
| Market cap | $146.2M | $131.1M |
| Today | −1.50% | −15.46% |
| 1 month | −37.0% | −17.1% |
| 6 months | −23.8% | — |
| Year to date | +42.5% | — |
| 1 year | +45.3% | — |
| Revenue growth (YoY) | +378.0% | — |
| Gross margin | 100.0% | — |
| Net margin | 59.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | — |
| Net cash | $173.3M | — |
| Dividend yield | — | — |
| Volatility (60d) | 113.6% | — |
| Short % of float | 8.2% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).